LEADER 01739nam  2200553Ia 450 
001 9910463201003321
005 20200520144314.0
010   $a1-62100-491-0
035   $a(CKB)2670000000370488
035   $a(EBL)3022365
035   $a(SSID)ssj0000886171
035   $a(PQKBManifestationID)11464527
035   $a(PQKBTitleCode)TC0000886171
035   $a(PQKBWorkID)10818018
035   $a(PQKB)10630455
035   $a(MiAaPQ)EBC3022365
035   $a(Au-PeEL)EBL3022365
035   $a(CaPaEBR)ebr10704556
035   $a(OCoLC)849920834
035   $a(EXLCZ)992670000000370488
100   $a20111102d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHeparin$b[electronic resource] $eproperties, uses and side effects /$fDavid E. Piyathilake and Rhong Liang, editors
210   $aHauppauge, NY $cNova Science Publisher's$dc2012
215   $a1 online resource (346 p.)
225 0 $aPharmacology - research, safety testing and regulation
300   $aDescription based upon print version of record.
311   $a1-62100-431-7 
320   $aIncludes bibliographical references and index.
410  0$aPharmacology - Research, Safety Testing and Regulation Biochemistry Research Trends
606   $aHeparin
606   $aAnticoagulants (Medicine)
608   $aElectronic books.
615  0$aHeparin.
615  0$aAnticoagulants (Medicine)
676   $a615.7/18
701   $aPiyathilake$b David E$0982747
701   $aLiang$b Rhong$0982748
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910463201003321
996   $aHeparin$92242707
997   $aUNINA